| Financial Year |
March 31 2023 |
| Monetary Funds |
1,210,687,717.28 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
23,853,512.74 |
| Advances to Suppliers |
9,108,595.49 |
| Other Receivables |
521,863.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
128,827,966.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,331.42 |
| Total Current Assets |
1,383,243,834.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
59,820,439.69 |
| Investment Properties |
14,949,978.37 |
| Fixed Assetes |
689,739,860.71 |
| Under-construction Projects |
418,200.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
154,601,518.44 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,278,617.94 |
| Deferred Income Tax Assets |
21,344,677.44 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
959,964,547.86 |
| Total Assets |
2,343,208,382.23 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
79,295,262.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,911,500.00 |
| Taxes Payable |
30,592,370.95 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
34,783,387.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,530,640.07 |
| Other Current Liabilities |
8,554,100.27 |
| Sub-Total of Current Liabilities |
251,716,756.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
67,277.35 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
25,150,240.50 |
| Total Liabilities |
276,866,996.51 |
| Paid-In Capital(Or Share Stock) |
646,051,647.00 |
| Capital Surplus |
104,916,962.66 |
| Surplus Reserve |
325,541,611.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,086,776,206.18 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,066,341,385.72 |
| Owner's Equity（Stockholder's Equity） |
2,066,341,385.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,343,208,382.23 |
